Dr. Michael Siegenthaler, associate professor of surgery and associate director of the Artificial Heart Program at the University of Pittsburg, will discuss the current state of the art of ventricular assist devices and the artificial heart as an alternative therapy for end stage heart failure patients.
Will the Artificial Heart Become Reality?
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Dr. Michael Siegenthaler, associate professor of surgery and associate director of the Artificial Heart Program at the University of Pittsburg, will discuss the current state of the art of ventricular assist devices and the artificial heart as an alternative therapy for end stage heart failure patients.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Phase 3 study results of plozasiran in patients with FCS
FCS and SHTG: Are We Meeting the Need?
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: Systemic Disease Infiltrating the Skull Base
IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement
IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue
Level Up Your Skills: Tailoring Management of HF
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?